Company profile
Braveheart Bio, Inc. Insider Trading
BRVEEvery SEC Form 4 insider trading filing for Braveheart Bio, Inc. (BRVE) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?
- Exchange
- Nasdaq
- Sector
- Pharmaceutical Preparations
- CIK
- 0002131524
- Filings
- 14
- Insiders
- 21
- Last filing
- 2026-08-07
Activity summary
Recent insider activity is bullish. Over the last 30 days, 22 insiders purchased shares (net $159.0M). Buying was led by Forbion Growth Opportunities Fund III Cooperatief U.A..
90 day insight
Over the last 90 days, Braveheart Bio, Inc. insiders bought $159.0M across 22 transactions with no open-market sales.
- Most active insider: Forbion Growth Opportunities Fund III Cooperatief U.A. with 6 transactions totaling $64.8M.
- Largest single purchase: $34.6M by Forbion Growth Opportunities Fund III Cooperatief U.A. on Aug 7, 2026.
Activity skews bullish — buys outpace sales.
Insider Transactions
Sourced from SEC EDGAR Form 4 filings. Updated hourly.
| Date | Insider | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | AH Bio Fund IV, L.P. | BRVE | C | 40,000,000 | — | — |
| Aug 7, 2026 | Lubner David Charles | BRVE | Purchase | 55,555 | $18.00 | $1000K |
| Aug 7, 2026 | Orbimed Advisors LLC | BRVE | Purchase | 1,666,667 | $18.00 | $30.00M |
| Aug 7, 2026 | Orbimed Advisors LLC | BRVE | Purchase | 273,333 | $18.00 | $4.92M |
| Aug 7, 2026 | Orbimed Advisors LLC | BRVE | C | 40,000,000 | — | — |
29 more transactions hidden
Free account · No credit card required
Building something? Get API access →
Query this yourself
The same rows, over the API.
curl "https://api.form4api.com/v1/transactions?ticker=BRVE" \
-H "X-Api-Key: $KEY"Top insiders
By total value filed.